🇺🇸 Colloids in United States
11 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 11
Most-reported reactions
- Sepsis — 2 reports (18.18%)
- Acute Respiratory Distress Syndrome — 1 report (9.09%)
- Colonic Pseudo-Obstruction — 1 report (9.09%)
- Confusional State — 1 report (9.09%)
- Cyanosis — 1 report (9.09%)
- Dizziness — 1 report (9.09%)
- Drug Level Below Therapeutic — 1 report (9.09%)
- Drug Toxicity — 1 report (9.09%)
- General Physical Health Deterioration — 1 report (9.09%)
- Haemodynamic Instability — 1 report (9.09%)
Other Other approved in United States
Frequently asked questions
Is Colloids approved in United States?
Colloids does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Colloids in United States?
University of Versailles is the originator. The local marketing authorisation holder may differ — check the official source linked above.